Olokizumab
From Wikipedia, the free encyclopedia
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized |
Target | IL6 |
Clinical data | |
Legal status | ? |
Identifiers | |
CAS number | 1007223-17-7 |
ATC code | None |
Chemical data | |
Formula | ? |
(what is this?) (verify) | |
Olokizumab is an immunomodulator. It binds to interleukin 6.[1]
References
- ↑ World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 103" (PDF). WHO Drug Information.
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.